Found 5 matching trials
A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use
PHASE1A \[68\]Ga-HA-DOTATATE PET/CT or PET/MRI scan is a nuclear medicine test us...
Location
Cross Cancer Institute
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
N/ATo determine if 68Ga-HA-DOTATATE PET/CT imaging is effective at diagnosing ...
Location
Foothills Medical Center 1403 29 St NW
Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors
PHASE2This study is a single centre non-randomized non-blinded phase II prospecti...
Status
Active Not Recruiting
Location
University of Alberta Hospital
68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
NAThis trial studies how well 68Ga-DOTATATE digital PET/CT work in diagnosing...
Location
Ohio State University Comprehensive Cancer Center
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
PHASE2Somatostatin receptor (SSR) imaging is a critical component of clinical car...
Location
University of Alberta